• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lipid metabolism in cancer cachexia.癌症恶病质中的脂质代谢
Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.
2
Metabolic substrate utilization by tumour and host tissues in cancer cachexia.癌症恶病质中肿瘤组织与宿主组织的代谢底物利用情况
Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):321-6. doi: 10.1042/bj2770321.
3
Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia.MAC16诱导的癌症恶病质中棕色脂肪解偶联蛋白(UCP)1以及骨骼肌UCP2和UCP3的基因表达增加。
Cancer Res. 2000 May 1;60(9):2405-10.
4
Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.携带结肠腺癌的小鼠肿瘤组织和宿主组织中的脂肪生成
Br J Cancer. 1991 May;63(5):719-22. doi: 10.1038/bjc.1991.162.
5
Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.重组肿瘤坏死因子诱导的体重减轻与恶病质诱导肿瘤所产生的体重减轻的比较。
Br J Cancer. 1988 Apr;57(4):385-9. doi: 10.1038/bjc.1988.87.
6
Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.降脂药物苯扎贝特对体内肿瘤生长速率的影响。
Br J Cancer. 1991 Dec;64(6):1035-8. doi: 10.1038/bjc.1991.460.
7
Mechanism of muscle protein degradation in cancer cachexia.癌症恶病质中肌肉蛋白降解的机制。
Br J Cancer. 1993 Aug;68(2):314-8. doi: 10.1038/bjc.1993.334.
8
Catabolic factors in cancer cachexia.癌症恶病质中的分解代谢因素。
In Vivo. 1996 Mar-Apr;10(2):131-6.
9
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice.癌症恶病质中的脂肪萎缩:荷瘤小鼠脂肪组织的形态学和分子分析
Br J Cancer. 2006 Oct 23;95(8):1028-37. doi: 10.1038/sj.bjc.6603360. Epub 2006 Oct 3.
10
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.一种肿瘤源性脂质动员因子对体内葡萄糖和脂质代谢的影响。
Br J Cancer. 2002 Aug 27;87(5):580-4. doi: 10.1038/sj.bjc.6600493.

引用本文的文献

1
Cancer cachexia: multilevel metabolic dysfunction.癌症恶病质:多级代谢功能障碍。
Nat Metab. 2024 Dec;6(12):2222-2245. doi: 10.1038/s42255-024-01167-9. Epub 2024 Nov 22.
2
Cancer cachexia: lessons from Drosophila.癌症恶病质:来自果蝇的经验教训。
Dis Model Mech. 2022 Mar 1;15(3). doi: 10.1242/dmm.049298. Epub 2022 Mar 23.
3
Energy metabolism in cachexia.恶病质中的能量代谢。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201847258. Epub 2019 Mar 19.
4
Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.了解癌症恶病质中的肿瘤合成代谢和患者分解代谢。
Am J Cancer Res. 2017 May 1;7(5):1107-1135. eCollection 2017.
5
Raman Spectroscopic Analysis Reveals Abnormal Fatty Acid Composition in Tumor Micro- and Macroenvironments in Human Breast and Rat Mammary Cancer.拉曼光谱分析揭示了人类乳腺和大鼠乳腺癌肿瘤微环境和宏环境中脂肪酸组成的异常。
Sci Rep. 2016 Sep 6;6:32922. doi: 10.1038/srep32922.
6
Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells.化疗诱导癌症相关成纤维细胞表型,激活乳腺癌细胞中的旁分泌刺猬索尼克-胶质瘤相关蛋白信号通路。
Oncotarget. 2015 May 10;6(13):10728-45. doi: 10.18632/oncotarget.3828.
7
Pharmacokinetics of drugs in cachectic patients: a systematic review.恶液质患者中药物的药代动力学:系统评价。
PLoS One. 2013 Nov 8;8(11):e79603. doi: 10.1371/journal.pone.0079603. eCollection 2013.
8
Mechanisms linking obesity and cancer.肥胖与癌症的关联机制。
Biochim Biophys Acta. 2013 Oct;1831(10):1499-508. doi: 10.1016/j.bbalip.2013.02.008. Epub 2013 Mar 5.
9
Community of protein complexes impacts disease association.蛋白质复合物群落影响疾病关联。
Eur J Hum Genet. 2012 Nov;20(11):1162-7. doi: 10.1038/ejhg.2012.74. Epub 2012 May 2.
10
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.一种肿瘤源性脂质动员因子对体内葡萄糖和脂质代谢的影响。
Br J Cancer. 2002 Aug 27;87(5):580-4. doi: 10.1038/sj.bjc.6600493.

本文引用的文献

1
Metabolic effects of infused triglyceride.输注甘油三酯的代谢效应。
Metabolism. 1961 May;10:403-14.
2
Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.从腹水肉瘤180的无细胞液中纯化和鉴定一种脂解因子(毒素激素-L)。
Cancer Res. 1981 Jan;41(1):284-8.
3
Host-tumor interaction and nutrient supply.宿主-肿瘤相互作用与营养供应。
Cancer. 1980 Jun 15;45(12):2940-8. doi: 10.1002/1097-0142(19800615)45:12<2940::aid-cncr2820451208>3.0.co;2-p.
4
Characterization of a lipid mobilizing factor from tumors.肿瘤来源的脂质动员因子的特性分析
Prog Lipid Res. 1981;20:823-6. doi: 10.1016/0163-7827(81)90155-7.
5
Intolerance to administered lipids in tumor-bearing animals.
Surgery. 1984 Aug;96(2):414-9.
6
Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes.急性链脲佐菌素诱导的糖尿病期间成年大鼠体内肿瘤生长的刺激作用。
Cancer Res. 1987 Apr 1;47(7):1756-61.
7
Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an acute fast.
Cancer Res. 1987 Feb 15;47(4):1065-8.
8
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.一种可移植的小鼠结肠腺癌的特征,该腺癌可使受体动物产生恶病质。
J Natl Cancer Inst. 1987 Mar;78(3):539-46.
9
Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal.哺乳期大鼠快速肿瘤生长对脂质代谢及窝仔清除的组织特异性影响。
Biochem J. 1988 May 15;252(1):65-72. doi: 10.1042/bj2520065.
10
Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.重组肿瘤坏死因子诱导的体重减轻与恶病质诱导肿瘤所产生的体重减轻的比较。
Br J Cancer. 1988 Apr;57(4):385-9. doi: 10.1038/bjc.1988.87.

癌症恶病质中的脂质代谢

Lipid metabolism in cancer cachexia.

作者信息

Mulligan H D, Beck S A, Tisdale M J

机构信息

CRC Experimental Chemotherapy Group, Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.

出版信息

Br J Cancer. 1992 Jul;66(1):57-61. doi: 10.1038/bjc.1992.216.

DOI:10.1038/bjc.1992.216
PMID:1637677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1977893/
Abstract

The effect of cancer cachexia on the oxidative metabolism of lipids has been studied in mice transplanted either with the MAC16 adenocarcinoma, which induces profound loss of body weight and depletion of lipid stores, or the MAC13 adenocarcinoma, which is the same histological type, but which grows without an effect on host body weight or lipid stores. While oxidation of D-[U-14C]glucose did not differ between animals bearing tumours of either type and non-tumour bearing controls, oxidation of [1-14C]triolein administered by intragastric intubation was significantly (P less than 0.05) higher in animals bearing the MAC16 tumour than in either non tumour-bearing controls or in animals bearing the MAC13 tumour. Intestinal absorption of [14C]lipid was significantly (P less than 0.05) reduced in animals bearing the MAC13 tumour when compared with either non tumour-bearing animals or MAC16 tumour-bearing animals, but was not significantly different in the latter two groups. The level of labelled lipids in heart and adipose tissue after an oral [14C]lipid load was significantly lower in animals bearing the MAC16 tumour compared with the other two groups. The level of tumour lipids was also higher in the MAC16 than in the MAC13 tumour after both an oral [14C]lipid load or by direct injection of [U-14C]palmitate complexed to albumin into epididymal fat pads. Oxidation of [U-14C]palmitate was also significantly enhanced in liver and heart homogenates from animals bearing the MAC16 tumour. These results suggest that in cachectic tumour-bearing animals mobilisation of body lipids is accompanied by an increased utilisation.

摘要

癌症恶病质对脂质氧化代谢的影响已在移植了MAC16腺癌或MAC13腺癌的小鼠中进行了研究。MAC16腺癌可导致体重显著下降和脂质储备消耗,而MAC13腺癌与MAC16腺癌组织学类型相同,但生长时对宿主体重或脂质储备无影响。虽然D-[U-14C]葡萄糖的氧化在携带这两种肿瘤类型的动物与未携带肿瘤的对照动物之间没有差异,但通过胃内插管给予的[1-14C]甘油三酯的氧化在携带MAC16肿瘤的动物中显著(P<0.05)高于未携带肿瘤的对照动物或携带MAC13肿瘤的动物。与未携带肿瘤的动物或携带MAC16肿瘤的动物相比,携带MAC13肿瘤的动物中[14C]脂质的肠道吸收显著(P<0.05)降低,但后两组之间没有显著差异。口服[14C]脂质负荷后,携带MAC16肿瘤的动物心脏和脂肪组织中标记脂质的水平显著低于其他两组。口服[14C]脂质负荷或通过将与白蛋白复合的[U-14C]棕榈酸酯直接注射到附睾脂肪垫后,MAC16肿瘤中的肿瘤脂质水平也高于MAC13肿瘤。来自携带MAC16肿瘤的动物的肝脏和心脏匀浆中[U-14C]棕榈酸酯的氧化也显著增强。这些结果表明,在患有恶病质的荷瘤动物中,身体脂质的动员伴随着利用率的增加。